Navigation Links
Cardiome Provides Regulatory Update
Date:10/9/2008


NASDAQ: CRME TSX: COM

VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has been informed by its co-development partner, Astellas Pharma US, Inc., that an End of Review meeting with the U.S. Food & Drug Administration (FDA) has been scheduled for November 14th, 2008 regarding the New Drug Application (NDA) for KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. At the conclusion of FDA's review of an application and the issuance of an action letter, FDA provides applicants with an opportunity to meet with agency reviewing officials to discuss what further steps need to be taken by the applicant before the application can be approved.

Cardiome has also been informed by Astellas that, in an effort to align the North American regulatory strategy, Astellas has elected to withdraw the New Drug Submission (NDS) for KYNAPID with the Therapeutic Products Directorate (TPD) of Health Canada, originally submitted in May 2007. Cardiome and Astellas intend to revisit the Canadian regulatory strategy following resolution of the FDA process.

"Since receiving the FDA Approvable Letter in August, Cardiome and Astellas have been working diligently to collate information and analyses relevant to the issues raised in the action letter, and this meeting is intended to provide us with clear guidance so that we can focus our efforts on providing a robust response and attain U.S. approval for KYNAPID," said Bob Rieder, Chief Executive Officer of Cardiome. "We look forward to working with the FDA with the goal of having KYNAPID available to appropriate patients as soon as possible."

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome To Release Second Quarter Results And Hold Conference Call
2. Cardiome Announces Preferred Share Financing
3. Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
4. Cardiome To Hold Conference Call
5. Cardiome Reports First Quarter Results
6. Cardiome To Release 2008 First Quarter Results
7. Cardiome To Release 2007 Results
8. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
9. Cardiome And Astellas Announce Regulatory Update
10. Cardiome to Hold Investor Update Call
11. Cardiome Updates Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... 2015 , ... According to an article published August 4th by ... data showing that it is safe for pregnant women to undergo local anesthesia needed ... local anesthesia with a group that hadn’t, researchers were able to determine that “local ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed an ... , Schmidt National Law Group, a leading firm in mass-tort litigation, has filed ... Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have been ...
(Date:9/4/2015)... Marietta, GA (PRWEB) , ... September 04, 2015 , ... ... team is in desperate need of new apparel. In an effort to assist the ... around Marietta, has launched a charity drive to raise funds for the new uniforms. ...
(Date:9/4/2015)... Valley Forge, PA (PRWEB) , ... September 04, 2015 , ... ... mold growth in and around the home is quite common. Mold can grow anywhere ... as areas around leaking pipes. Checking for excessive moisture and water in the home ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... that head and neck cancer treatments fail is the tumor ... University of Michigan Comprehensive Cancer Center have found that a ... overcome that resistance. When researchers added a curcumin-based ... they were able to cut the dose of the chemotherapy ...
... A University of Missouri researcher has found that eating ... satiety and reduces hunger throughout the day. In addition, ... that eating a protein-rich breakfast reduces the brain signals ... knows that eating breakfast is important, but many people ...
... Barcelona researchers have discovered that Viagra drastically reduces multiple ... research, published in Acta Neuropathologica , demonstrates that ... animals after eight days of treatment. Researchers are confident ... patients given that the drug is well tolerated and ...
... The American Society of Clinical Oncology (ASCO) today ... more than 4,000 abstracts publicly posted online at www.asco.org ... additional 17 plenary, late-breaking and other major studies will ... Meeting. The meeting, which is expected ...
... , THURSDAY, May 19 (HealthDay News) -- Problem gambling ... especially online, of gambling opportunities, said experts who called ... the disorder. While most people gamble as an ... too seriously involved in terms of time invested and ...
... RECOMMENDS WAYS TO ENSURE ACCESS TO AFFORDABLE INSURANCE IS ... Combined Small Business and Individual Health Insurance Exchanges Could ... New York, NY, May 19, 2011Modifications to current policies ... provided under the Affordable Care Act remain stable even ...
Cached Medicine News:Health News:Curcumin compound improves effectiveness of head and neck cancer treatment, U-M study finds 2Health News:Eat a protein-rich breakfast to reduce food cravings, prevent overeating later, researcher finds 2Health News:Viagra could reduce multiple sclerosis symptoms 2Health News:ASCO releases studies from upcoming annual meeting 2Health News:ASCO releases studies from upcoming annual meeting 3Health News:Internet Is Playing a Part in Spread of Problem Gambling 2Health News:New report on health reform implementation: How to ensure access to coverage is maintained 2Health News:New report on health reform implementation: How to ensure access to coverage is maintained 3
(Date:9/4/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... the upcoming Rodman & Renshaw 17 th Annual ... New York City .  Dr. ... corporate overview on September 9, 2015. ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
(Date:9/4/2015)... Sep. 04, 2015 ... has announced the addition of the ... 2010-2019" report to their offering. ... containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As ... cartilage matrix, sodium hyaluronate can lubricate the ...
Breaking Medicine Technology:Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... 1 October is American Pharmacists Month and ... provide outstanding care to their patients every day ... specialty pharmacies across the country. (Logo: ... Pharmacists Month is a time to recognize the ...
... national initiative, the Pediatric Trials Network (PTN), was created ... the National Institutes of Health (NIH).  The PTN will ... Shriver National Institute of Child Health and Human ... medical centers, including Children,s Mercy Hospitals and Clinics.   ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2New National Program to Study and Establish Pediatric Dosing 2New National Program to Study and Establish Pediatric Dosing 3
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
... Coronary Stent System is Guidant's first in ... Cobalt chromium is stronger and more radiopaque ... stent can have similar strength and visibility ... struts that are only .0032" thick. Thinner ...
Medicine Products: